• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于鉴定新型利什曼原虫主要蛋白二硫键异构酶抑制剂以治疗利什曼病的计算机辅助方法。

A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis.

作者信息

Ben Khalaf Noureddine, Pham Susie, Romeo Giuseppe, Abdelghany Sara, Intagliata Sebastiano, Sedillo Peter, Salerno Loredana, Gonzales Jessica, Fathallah Dahmani M, Perkins Douglas J, Hurwitz Ivy, Pittalà Valeria

机构信息

Department of Life Sciences, Health Biotechnology Program, College of Graduates Studies, King Fahd Chair for Health Biotechnology, Arabian Gulf University, Road 2904 Building 293, Manama, 329, Kingdom of Bahrain.

Center for Global Health, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

出版信息

J Comput Aided Mol Des. 2021 Mar;35(3):297-314. doi: 10.1007/s10822-021-00374-w. Epub 2021 Feb 22.

DOI:10.1007/s10822-021-00374-w
PMID:33615401
Abstract

Leishmaniasis is an infectious disease caused by parasites of the genus Leishmania and transmitted by the bite of a sand fly. To date, most available drugs for treatment are toxic and beyond the economic means of those affected by the disease. Protein disulfide isomerase (PDI) is a chaperone protein that plays a major role in the folding of newly synthesized proteins, specifically assisting in disulfide bond formation, breakage, or rearrangement in all non-native proteins. In previous work, we demonstrated that Leishmania major PDI (LmPDI) has an essential role in pathogen virulence. Furthermore, inhibition of LmPDI further blocked parasite infection in macrophages. In this study, we utilized a computer-aided approach to design a series of LmPDI inhibitors. Fragment-based virtual screening allowed for the understanding of the inhibitors' modes of action on LmPDI active sites. The generated compounds obtained after multiple rounds of virtual screening were synthesized and significantly inhibited target LmPDI reductase activity and were shown to decrease in vitro parasite growth in human monocyte-derived macrophages. This novel cheminformatics and synthetic approach led to the identification of a new series of compounds that might be optimized into novel drugs, likely more specific and less toxic for the treatment of leishmaniasis.

摘要

利什曼病是一种由利什曼原虫属寄生虫引起的传染病,通过白蛉叮咬传播。迄今为止,大多数现有的治疗药物都有毒性,超出了该病患者的经济承受能力。蛋白质二硫键异构酶(PDI)是一种伴侣蛋白,在新合成蛋白质的折叠过程中起主要作用,特别是在所有非天然蛋白质的二硫键形成、断裂或重排方面提供协助。在先前的研究中,我们证明了硕大利什曼原虫PDI(LmPDI)在病原体毒力中起着至关重要的作用。此外,抑制LmPDI可进一步阻断寄生虫在巨噬细胞中的感染。在本研究中,我们采用计算机辅助方法设计了一系列LmPDI抑制剂。基于片段的虚拟筛选有助于了解抑制剂对LmPDI活性位点的作用模式。经过多轮虚拟筛选生成的化合物被合成出来,它们显著抑制了目标LmPDI还原酶活性,并显示出可降低人单核细胞衍生巨噬细胞中寄生虫的体外生长。这种新颖的化学信息学和合成方法导致鉴定出了一系列新的化合物,这些化合物可能被优化成新型药物,有望在治疗利什曼病时更具特异性且毒性更低。

相似文献

1
A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis.一种用于鉴定新型利什曼原虫主要蛋白二硫键异构酶抑制剂以治疗利什曼病的计算机辅助方法。
J Comput Aided Mol Des. 2021 Mar;35(3):297-314. doi: 10.1007/s10822-021-00374-w. Epub 2021 Feb 22.
2
Leishmania major protein disulfide isomerase as a drug target: enzymatic and functional characterization.主要利什曼原虫蛋白二硫键异构酶作为药物靶点:酶学和功能特征。
Parasitol Res. 2012 May;110(5):1911-7. doi: 10.1007/s00436-011-2717-5. Epub 2011 Dec 9.
3
A high-throughput turbidometric assay for screening inhibitors of Leishmania major protein disulfide isomerase.一种用于筛选杜氏利什曼原虫蛋白二硫键异构酶抑制剂的高通量比浊法检测
J Biomol Screen. 2011 Jun;16(5):545-51. doi: 10.1177/1087057111401026. Epub 2011 Mar 25.
4
Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor.鉴定大利什曼原虫的一种二硫键异构酶蛋白为一种假定的毒力因子。
Infect Immun. 2002 Jul;70(7):3576-85. doi: 10.1128/IAI.70.7.3576-3585.2002.
5
Design, synthesis and evaluation of protein disulfide isomerase inhibitors with nitric oxide releasing activity.具有一氧化氮释放活性的蛋白二硫键异构酶抑制剂的设计、合成与评价。
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126898. doi: 10.1016/j.bmcl.2019.126898. Epub 2019 Dec 17.
6
A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.一种小分子抑制蛋白质二硫键异构酶并引发癌细胞的化学增敏作用。
Angew Chem Int Ed Engl. 2014 Nov 17;53(47):12960-5. doi: 10.1002/anie.201406577. Epub 2014 Sep 26.
7
Protein disulfide isomerase (PDI) associates with NADPH oxidase and is required for phagocytosis of Leishmania chagasi promastigotes by macrophages.蛋白质二硫键异构酶(PDI)与NADPH氧化酶相关联,是巨噬细胞吞噬恰加斯利什曼原虫前鞭毛体所必需的。
J Leukoc Biol. 2009 Oct;86(4):989-98. doi: 10.1189/jlb.0608354. Epub 2009 Jun 29.
8
Structural modeling and docking studies of ribose 5-phosphate isomerase from Leishmania major and Homo sapiens: a comparative analysis for Leishmaniasis treatment.硕大利什曼原虫和人类核糖-5-磷酸异构酶的结构建模与对接研究:利什曼病治疗的比较分析
J Mol Graph Model. 2015 Feb;55:134-47. doi: 10.1016/j.jmgm.2014.11.002. Epub 2014 Dec 3.
9
Small molecule probe suitable for in situ profiling and inhibition of protein disulfide isomerase.适用于蛋白质二硫键异构酶原位分析和抑制的小分子探针。
ACS Chem Biol. 2013 Nov 15;8(11):2577-85. doi: 10.1021/cb4002602. Epub 2013 Sep 26.
10
Identification and enzymatic activities of four protein disulfide isomerase (PDI) isoforms of Leishmania amazonensis.亚马逊利什曼原虫四种蛋白质二硫键异构酶(PDI)亚型的鉴定及酶活性
Parasitol Res. 2008 Feb;102(3):437-46. doi: 10.1007/s00436-007-0784-4. Epub 2007 Dec 6.

引用本文的文献

1
Determination of key hub genes in Leishmaniasis as potential factors in diagnosis and treatment based on a bioinformatics study.基于生物信息学研究的利什曼病关键枢纽基因的鉴定及其在诊断和治疗中的潜在作用。
Sci Rep. 2024 Sep 28;14(1):22537. doi: 10.1038/s41598-024-73779-w.

本文引用的文献

1
Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of .潜在 Th1 刺激蛋白的 T 细胞表位的免疫原性和保护效力
Front Immunol. 2019 Feb 28;10:288. doi: 10.3389/fimmu.2019.00288. eCollection 2019.
2
Structural basis for pH-dependent retrieval of ER proteins from the Golgi by the KDEL receptor.KDEL 受体介导内质网蛋白从高尔基体 pH 依赖性回收的结构基础。
Science. 2019 Mar 8;363(6431):1103-1107. doi: 10.1126/science.aaw2859.
3
Bioinformatics analysis of four proteins of Leishmania donovani to guide epitopes vaccine design and drug targets selection.
杜氏利什曼原虫四种蛋白质的生物信息学分析以指导表位疫苗设计和药物靶点选择。
Acta Trop. 2019 Mar;191:50-59. doi: 10.1016/j.actatropica.2018.12.035. Epub 2018 Dec 21.
4
Chemoinformatics Strategies for Leishmaniasis Drug Discovery.用于利什曼病药物发现的化学信息学策略
Front Pharmacol. 2018 Nov 1;9:1278. doi: 10.3389/fphar.2018.01278. eCollection 2018.
5
Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.为什么米替福新这种治疗利什曼病的救命药物,却无法提供给最需要它的人。
BMJ Glob Health. 2018 May 3;3(3):e000709. doi: 10.1136/bmjgh-2018-000709. eCollection 2018.
6
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.发现苯并咪唑类墨西哥利什曼原虫半胱氨酸蛋白酶 CPB2.8ΔCTE 抑制剂可作为治疗利什曼病的潜在疗法。
Chem Biol Drug Des. 2018 Sep;92(3):1585-1596. doi: 10.1111/cbdd.13326. Epub 2018 May 31.
7
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.利什曼病中的耐药性与治疗失败:21世纪的挑战。
PLoS Negl Trop Dis. 2017 Dec 14;11(12):e0006052. doi: 10.1371/journal.pntd.0006052. eCollection 2017 Dec.
8
Working towards New Drugs against Parasitic Worms in a Public-Development Partnership.在公共发展伙伴关系中努力研发新的抗寄生虫药物。
Trends Parasitol. 2018 Jan;34(1):4-6. doi: 10.1016/j.pt.2017.07.005. Epub 2017 Aug 4.
9
Combinatorial chemistry in drug discovery.药物研发中的组合化学。
Curr Opin Chem Biol. 2017 Jun;38:117-126. doi: 10.1016/j.cbpa.2017.03.017. Epub 2017 May 8.
10
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.SwissADME:一个免费的网络工具,用于评估小分子的药代动力学、类药性和药物化学友善性。
Sci Rep. 2017 Mar 3;7:42717. doi: 10.1038/srep42717.